Gatica Sebastian, Aravena Diego, Echeverría Cesar, Santibanez Juan F, Riedel Claudia A, Simon Felipe
Laboratory of Integrative Physiopathology, Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
Adv Exp Med Biol. 2023;1408:49-63. doi: 10.1007/978-3-031-26163-3_3.
Catecholamine stimulation over adrenergic receptors results in a state of hypercoagulability. Chronic stress involves the release and increase in circulation of catecholamines and other stress related hormones. Numerous observational studies in human have related stressful scenarios to several coagulation variables, but controlled stimulation with agonists or antagonists to adrenergic receptors are scarce. This systematic review is aimed at presenting an updated appraisal of the effect of adrenergic receptor modulation on variables related to human hemostasis by systematically reviewing the effect of adrenergic receptor-targeting drugs on scale variables related to hemostasis. By searching 3 databases for articles published between January 1st 2011 and February 16th, 2022 reporting effects on coagulation parameters from stimulation with α- or β-adrenergic receptor targeting drugs in humans regardless of baseline condition, excluding records different from original research and those not addressing the main aim of this systematic review. Risk of bias assessed using the Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). Tables describing a pro-thrombotic anti-fibrinolytic state induced after β-adrenergic receptor agonist stimulation and the opposite after α-, β-adrenergic receptor antagonist stimulation were synthesized from 4 eligible records by comparing hemostasis-related variables to their baseline. Notwithstanding this low number of records, experimental interventions included were sound and mostly unbiased, results were coherent, and outcomes were biologically plausible. In summary, this systematic review provides a critical systematic assessment and an updated elaboration, and its shortcomings highlight the need for further investigation in the field of hematology.
儿茶酚胺对肾上腺素能受体的刺激会导致高凝状态。慢性应激会导致儿茶酚胺和其他与应激相关的激素释放并在循环中增加。众多针对人类的观察性研究已将应激情况与多种凝血变量联系起来,但使用激动剂或拮抗剂对肾上腺素能受体进行控制性刺激的研究却很少。本系统评价旨在通过系统回顾针对肾上腺素能受体的药物对与止血相关的量表变量的影响,对肾上腺素能受体调节对与人类止血相关变量的影响进行最新评估。通过在3个数据库中搜索2011年1月1日至2022年2月16日期间发表的文章,这些文章报告了无论基线情况如何,α或β肾上腺素能受体靶向药物刺激对人类凝血参数的影响,排除与原始研究不同以及未涉及本系统评价主要目的的记录。使用修订后的Cochrane随机试验偏倚风险工具(RoB 2)评估偏倚风险。通过将与止血相关的变量与其基线进行比较,从4条符合条件的记录中合成了描述β肾上腺素能受体激动剂刺激后诱导的促血栓形成抗纤溶状态以及α、β肾上腺素能受体拮抗剂刺激后相反状态的表格。尽管记录数量较少,但纳入的实验干预是合理的且大多无偏倚,结果是一致的,并且结果在生物学上是合理的。总之,本系统评价提供了一项关键的系统评估和最新阐述,其不足之处凸显了血液学领域进一步研究的必要性。